Identification of antibiotic induced persister cells in Streptococcus agalactiae

Nanna Boll Greve1, Hans-Christian Slotved2, John Elmerdahl Olsen1

  • 1Faculty of Health and Medical Sciences, Department of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg C, Denmark.

Plos One
|June 26, 2024
PubMed

Insights

Antibiotic persister cells in Streptococcus agalactiae can survive antibiotic treatment, potentially explaining recurrent infections. This trait is common across clinical isolates and influenced by growth phase and antibiotic type.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Antibiotic persistence involves a small bacterial fraction surviving lethal antibiotic doses.
  • Persister cells are linked to recurrent infections, posing a clinical challenge.
  • Streptococcus agalactiae causes invasive infections, with reported recurrence in neonates and adults.

Purpose of the Study:

  • To investigate the formation of persister cells in Streptococcus agalactiae.
  • To determine factors influencing persister cell frequency in S. agalactiae.
  • To assess the prevalence of persister cell formation in clinical isolates.

Main Methods:

  • Exposure of S. agalactiae NEM316 to various antibiotic classes.
  • Analysis of persister cell formation across different bacterial growth phases.
  • Testing penicillin-induced persister cell formation in diverse clinical S. agalactiae isolates.

Main Results:

  • S. agalactiae forms persister cells when exposed to different antibiotic classes.
  • Persister cell formation frequency is dependent on bacterial growth phase and antibiotic class.
  • Penicillin-induced persister cell formation is a conserved trait in clinical S. agalactiae isolates.

Conclusions:

  • Antibiotic-tolerant S. agalactiae persister cells exist.
  • The presence of persister cells may explain treatment persistence and recurrent infections.
  • This finding has implications for managing S. agalactiae infections.